NOVEL COMPOUNDS FOR IRON DEFICIENCY ANEMIA IN PREGNANCY

Background: Iron deficiency anemia(IDA) remains a significant health challenge during pregnancy, adversely affecting both maternal and fetal outcomes. Despite the common use of oral iron supplements, their efficacy is often hindered by gastrointestinal side effects, leading to poor compliance. Intravenous iron therapies, such as ferric carboxymaltose (FCM) and iron (III) isomaltoside, have emerged as superior alternatives due to their ability to rapidly replenish iron stores and normalize hemoglobin levels